1768
N. K. Christensen et al. / Bioorg. Med. Chem. Lett. 11 (2001) 1765–1768
imidine sequence, suggesting that the N-conformation is
preferable for the reverse b-nucleoside in this duplex
type. This confirms the potential of conformationally
locked nucleosides in ODNs also with polarity reversals
and indicates that more improved thermal stabilities
might be obtained in other sequences with chimeras of
conformationally restricted a- and b-nucleosides. Taken
together, our results and the NMR analyses (vide supra)
indicate that other conformational restrictions can
afford ODNs with higher binding affinities, for example
by incorporating restricted monomers up- or down-
stream of the polarity reversals. Furthermore, the fact
that a/b-chimeras with polarity reversals in some
duplexes with RNA induce RNaseH mediated cleavage
of the RNA strand14 and the fact that one incorpora-
tion of (b-)LNA does not significantly destabilise duplex
stability suggest, in combination, that chimeras of a/b-
LNA and other modified or unmodified nucleosides
might be useful in the construction of conformationally
restricted high-affinity ODNs with the ability of indu-
cing RNaseH mediated degradation of the target RNA.
5. Koshkin, A. A.; Singh, S. K.; Nielsen, P.; Rajwanshi, V. K.;
Kumar, R.; Meldgaard, M.; Olsen, C. E.; Wengel, J. Tetra-
hedron 1998, 54, 3607.
6. Wengel, J. Acc. Chem. Res. 1999, 32, 301.
7. Morvan, F.; Rayner, B.; Imbach, J.-L.; Thenet, S.; Ber-
trand, J.-R.; Paoletti, J.; Malvy, C.; Paoletti, C. Nucleic Acids
Res. 1987, 15, 3421.
8. Morvan, F.; Porumb, H.; Degols, G.; Lefebvre, I.; Pom-
pon, A.; Sproat, B. S.; Rayner, B.; Malvy, C.; Lebleu, B.;
Imbach, J.-L. J. Med. Chem. 1993, 36, 280.
9. Gagnor, C.; Rayner, B.; Leonetti, J.-P.; Imbach, J.-L.;
Lebleu, B. Nucleic Acids Res. 1989, 17, 5107.
10. Nielsen, P.; Dalskov, J. K. Chem. Commun. 2000, 1179.
11. Debart, F.; Tosquellas, G.; Rayner, B.; Imbach, J.-L.
Bioorg. Med. Chem. Lett. 1994, 4, 1041.
12. Boiziau, C.; Debart, F.; Rayner, B.; Imbach, J.-L.;
Toulme, J.-J. FEBS Lett. 1995, 361, 41.
13. Aramini, J. M.; Germann, M. W. Biochemistry 1999, 38,
15448.
14. Tan, T. M. C.; Kalisch, B. W.; van de Sande, J. H.; Ting,
R. C. Y.; Tan, Y. H. Antisense Nucleic Acid Drug Dev. 1998, 8,
95.
15. Koga, M.; Wilk, A.; Moore, M. F.; Scremin, C. L.; Zhou,
L.; Beaucage, S. L. J. Org. Chem. 1995, 60, 1520.
16. Aramini, J. M.; van de Sande, J. H.; Germann, M. W.
Biochemistry 1997, 36, 9715.
In conclusion, we have demonstrated the efficient
incorporation of conformationally locked a- and b-
LNA monomers into ODNs with polarity reversals. In
this context, we have efficiently synthesised a 50-O-
phosphoramidite of an LNA monomer. In accordance
with the NMR examination by Germann and co-work-
ers,13,25 our results suggest that the binding affinity of
ODNs containing a-nucleosides with polarity reversals
might instead be significantly improved by a-nucleoside
analogues that are conformationally restricted in S-type
conformations. The development of other con-
formationally restricted a/b-chimeric ODNs with
potential high-affinity nucleic acid recognition and,
therefore, also antisense purposes is now in progress.
17. Caruthers, M. H. Acc. Chem. Res. 1991, 24, 278.
18. Kurfurst, R.; Roig, V.; Chassignol, M.; Asseline, U.;
¨
Thuong, N. T. Tetrahedron 1993, 49, 6975.
19. Tarkoy, M.; Bolli, M.; Leumann, C. Helv. Chim. Acta
¨
1994, 77, 716.
20. Selected data for 8: 1H NMR; dH (CDCl3, 300 MHz) 7.43–
7.22 (9H, m, arom.), 7.18 (1H, s, H-6), 6.81–6.77 (4H, m,
arom.), 5.46 (1H, s, H-10), 4.30 (1H, d, J 7.6 Hz, H-100),
4.02 (2H, m, H-50), 3.89 (1H, d, 7.6 Hz, H-100), 3.77 (3H,
s, OCH3), 3.76 (3H, s, OCH3), 3.66 (1H, s, H-20 or 30),
3.34 (1H, s, H-20 or 30), 1.79 (3H, s, CH3). HR-MALDI
MS; m/z found 595.2062, calcd for C32H32N2O8+Na
595.2051.
21. Selected data for 2: 31P NMR; dP (CDCl3, 121.5 MHz with
85% H3PO4 as external standard) 150.68, 150.85.
22. ODN 13 was synthesised on a 30-O-DMT-dC CPG-sup-
port from Chemgenes and cleaved using concentrated aqueous
ammonia. After the usual chromatography (Cruachem), the
sequence was >70% pure according to capillary gel electro-
phoresis.
23. MALDI MS data for oligonucleotide sequences: m/z
(found/calcd); 10 (4195.3/4195.8 Da); 11 (4223.6/4223.8 Da);
13 (2712.2/2712.8 Da); 14 (2742.1/2740.8 Da); 16 (4194.8/
4195.8 Da); 17 (4220.8/4223.8 Da); 19 (2976.7/2975.0 Da); 20
(3003.3/3003.0 Da).
Acknowledgements
The Danish Natural Science Research Council is
thanked for financial support. Ms. Malene Larsson is
thanked for synthetic assistance.
References and Notes
1. Herdewijn, P. Biochim. Biophys. Acta 1999, 1489, 167.
2. Meldgaard, M.; Wengel, J. J. Chem. Soc., Perkin Trans. 1
2000, 3539.
3. For the conformational behaviour of nucleosides and
nucleotides see: Saenger, W. Principles of Nucleic Acid Struc-
ture; Springer: New York, 1984.
24. All thermal stabilities of duplexes containing 15–20 were
also determined in a high salt buffer (750 mM NaCl) and the
expected increases were observed independent of the mod-
ifications.
25. Aramini, J. M.; Mujeeb, A.; Germann, M. W. Nucleic
Acids Res. 1998, 26, 5644.
4. Singh, S. K.; Nielsen, P.; Koshkin, A. A.; Wengel, J. Chem.
Commun. 1998, 455.
26. Aramini, J. M.; Mujeeb, A.; Ulyanov, N. B.; Germann,
M. W. J. Biomol. NMR 2000, 18, 287.